BANGALORE: Biotech major Biocon is selling its enzymes business to Denmark-based Novozymes for $115 million. The transaction, subject to shareholder and regulatory approvals, is expected to be completed by the end of the third quarter of 2007.
The move will enable Biocon to focus on its core...